FeesSafety
Pluang+

Enso's API now supports leveraged tokenized real-world asset strategies on Robinhood Chain.

Protocol Fundamentals
26 Oct 2026, 22:57 WIB
Tokenpost
View Source
Neutral
Enso's API now supports leveraged tokenized real-world asset strategies on Robinhood Chain.

Enso has expanded its execution API to support leveraged strategies involving tokenized real-world assets on the Robinhood Chain. This allows developers to combine collateral deposits, borrowing, swaps, and repeated borrowing into a single atomic transaction, simplifying complex financial operations. The feature builds on Enso's existing integration with Ethereum Layer 2 and leverages Robinhood Chain's public mainnet, which launched in July 2026 on the Arbitrum platform. While the announcement doesn't specify which assets are supported or accessible, this development could enhance decentralized finance applications by streamlining multi-step transactions on a network designed for financial services and tokenized assets.

Enso's new leveraged real-world asset strategies come as 16 of 50 major cryptocurrencies on Pluang rose while 32 fell. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 27, 2026 02:52 WIB: DOT (Polkadot) traded at Rp18.200 with a 1-day change of -2.84% and Pluang order activity of 27% Sell / 73% Buy; LUNC (Terra Classic) at Rp0,8 with -2.28% change and 49% Sell / 51% Buy; XTZ (Tezos) at Rp5.053 with -2.15% change and 71% Sell / 29% Buy. Typical hold times range from 101 to 196 days.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
2 hours ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App